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ABSTRACT  
 
G protein-coupled receptor kinases (GRKs) are emerging as important 
integrative nodes in cell migration processes. Recent evidence links GRKs (particularly 
the GRK2 isoform) to the complex modulation of diverse aspects of cell motility. In 
addition to its well-established role in the desensitization of G protein-coupled receptors 
involved in chemotaxis, GRK2 can play a effector role in the organization of actin and 
microtubule networks and in adhesion dynamics, by means of novel substrates and 
transient interacting partners, such as the GIT-1 scaffold or the cytoplasmic α-tubulin 
deacetylase histone deacetylase 6 (HDAC6). The overall effect of altering GRK levels 
or activity on chemotaxis would depend on how such different roles are integrated in a 
given cell type and physiological context, and may have relevant implications in 
inflammatory diseases or cancer progression. 
 
 
 
  
 
Introduction 
Cell migration plays a central role in physiological processes as embryogenesis, 
wound healing or immunity, whereas aberrant cell motility underlies pathological 
conditions such as inflammation or cancer progression  [1,2]. Chemotaxis integrates 
complex steps coordinated by transiently activated signalling networks, leading to cell 
polarization, membrane protrusion and generation of dynamic adhesion and traction 
forces [3, 4, 5]. 
Many G protein-coupled receptors (GPCR), such as those for chemokines, are 
involved in gradient sensing and cell migration [5,6]. Upon stimulation, GPCR initiate 
G protein-dependent signalling pathways and also become phosphorylated by 
serine/threonine kinases termed G protein-coupled receptor kinases (GRKs), of which 
GRK2 is the most ubiquitous and well-characterized [7,8]. This event promotes the 
association of arrestins, leading to GPCR desensitization and internalization. GRKs are 
emerging as complex regulators of cell migration processes, since their involvement in 
cell motility not only relies in their canonical role as “negative” modulators of GPCR 
signalling, but also involves novel substrates and interacting partners [8-11].  
We discuss herein recent evidence linking GRKs (particularly GRK2) to the 
different functional facets of cell migration, how such diverse roles might be 
orchestrated in response to stimuli, and the implications of these findings in physio-
pathological contexts.  
 
The conundrum of GRK2 in migration: how does GRK2 actually modulate 
the chemotactic response? 
Numerous reports have ascribed the effects of GRK2 on chemotaxis to its ability 
to trigger desensitization of particular chemokine receptors, thus controlling the 
intensity and duration of agonist stimulation [6,7,12]. Down-modulation of GRK2 
levels increases chemotactic responses to different agonists in immune cell types, 
whereas its enhanced expression attenuates chemotaxis, consistent with its canonical 
negative role in GPCR signalling (Table 1).  
However, the overall impact of GRK2 levels on cell migration is not 
straightforward and varies dependent on the stimuli and/or cell type considered [Table 
1, refs. 8-11]. GRK2 down-modulation can lead to decreased migration of immune cell 
types towards certain stimuli [13], and this kinase plays a positive role in epithelial cell 
migration [14].  
 These heterogeneous results raise questions about the functional role of GPCR 
desensitization during directed migration, and suggests that the global effect of GRK2 
on chemotaxis would depend on the integrated modulation of different steps of the 
chemotactic process (receptor sensing, cell polarization, membrane protrusion, 
adhesion/de-adhesion cycles) in given cell types and in response to specific stimuli.  
 
GRK2 in gradient sensing: a role for receptor phosphorylation? 
Directional sensing involves the conversion of graded receptor activation by 
chemoattractants into a sharp asymmetry of key downstream signalling components. 
PI3K and PTEN (besides other redundant pathways), are redistributed towards and 
away the gradient, respectively, allowing for local accumulation of PI(3,4,5)P3,, what 
serves to specify pseudopodia formation and to guide cell movement [15,16]. 
This response is extremely sensitive and localized PI(3,4,5)P3 production 
depends only on the gradient steepness [15, 16]. In steep gradients, cells generate a 
single, well-defined pseudopodium and move straight towards the signal source.  
Conversely, in shallow gradients, chemotaxis is mediated by biased choices between 
randomly projected pseudopodia, resulting in a tortuous and time-consuming tracking 
[3,5,16]. In steep gradients, high local fraction of receptor occupancy versus lower 
global occupancy would favour the generation of internal asymmetry [15]. In this 
context, it is tempting to suggest that GRK2-triggered receptor 
desensitization/internalization might influence how receptors sense the strength and 
steepness of chemotactic gradients (less GRK2, steeper, more GRK2, weaker gradients, 
see detailed model in Figure 1).  
 Consistently, GRK2 levels are important for defining the stop signal of 
neutrophil migration [17]. These cells adopt a random walk and cease directed 
locomotion when exposed to saturating concentrations of fMLP, which triggers receptor 
desensitization/internalization in a GRK2-dependent manner. Therefore, upon GRK2 
silencing cessation of migration is not achieved properly, resulting in sustained motility.  
Interestingly, dependence on steeper chemotactic gradients diminishes in 
polarized cells. Therefore, GRK2-mediated receptor phosphorylation/desensitization 
may become more relevant in immune cells, in contrast to intrinsically polarized 
epithelial cells and fibroblasts, leading to striking differences in how GRK2 impacts 
migration [9, 11, 14]. Receptor desensitization also might be more critical when cells 
migrate between opposed chemoattractant gradients. Notably, GRK2-mediated 
desensitization of S1P1 receptors allows T cells to “ignore” high vascular S1P 
concentrations in order to follow lymph node guiding cues [13, 18].  
 
GRK2 in cell polarization and membrane protrusion: shaping cells for 
motion 
 Cell polarization and the formation of a leading edge is a key step in chemotaxis. 
GRKs can also regulate these processes by modulating novel substrates and effectors 
(Figure 2), what would underpin the positive contribution of GRKs to chemotaxis in a 
stimuli- and cellular context-dependent manner. 
GRK-mediated GPCR phosphorylation promotes the recruitment of arrestins, which, in 
addition to their uncoupling/desensitizing function, have very important roles in cell 
migration by scaffolding key actin assembly proteins and protein kinase cascades in 
discrete cellular locations [5]. The precise sets of receptor residues phosphorylated by 
one or another GRK or by the same GRK in response to different stimuli [19-21] can 
engage distinct β-arrestin-conformation-dependent signalosomes with different 
functional competences. Therefore, the relative cellular GRK dosage or activation could 
modulate chemotaxis at this level. 
 More importantly, agonist-dependent recruitment of GRKs to the plasma 
membrane would also promote their direct modulation of specific effectors. The 
association of GRK2 to PI3Kγ in response to β2AR activation aided to recruit the lipid 
kinase to the receptor complex [22]. A similar interaction with PI3Ks upon chemokine 
or integrin receptor activation has not been reported, but this mechanism could reinforce 
gradient sensing.  
 GRK2 also interacts with and phosphorylates the ERM proteins ezrin and 
radixin in response to serum or muscarinic receptor activation [23,24]. By bridging the 
plasma membrane and actin filaments at the leading edge in a phosphorylation-
dependent manner, ERMs contribute to local F-actin polymerization-dependent 
membrane protrusion. Consistently, GRK2 stimulated cortical actin reorganization and 
migration in an ERM-mediated manner [23,24]. Interestingly, EGF induces ERM 
phosphorylation/translocation to lamellipodia via S1P receptor activation [25]. Since 
GRK2 positively modulates the chemotactic responses to EGF and S1P and plays 
effector roles in S1P signalling [14, 26], it is feasible that the GRK2/ERM module could 
also be triggered by additional chemotactic cues.  
 Besides, GRK2 can engage in pathways linked to polarity persistence by 
scaffolding GIT1 complexes [14]. GIT1 plays a central role in cell motility by acting as 
an adaptor protein that promotes Rac/PAK activation both at focal adhesions and at the 
cell leading edge [9,14]. The challenge of epithelial cells or fibroblasts by fibronectin or 
S1P causes G-dependent GRK2 translocation to the plasma membrane and GRK2-
mediated recruitment of GIT1. The transient GRK2/GIT1 interaction at the leading 
edge, controlled by the sequential phosphorylation of GRK2 by c-Src and MAPK, 
enhances Rac1 activation and results in F-actin cortical remodelling and increased 
migration [14]. 
 GRK2 also plays an important regulatory role in microtubule (MT) dynamics in 
these cell types [10,11,26].  MTs exert an overriding influence on the actin cytoskeleton 
and on the balance of the activity of Rho-family GTPases.  During cell migration, the 
MT cytoskeleton is polarized, and the protruding and retracting cell regions display 
different MT dynamics, associated proteins and posttranslational modifications. MTs 
become acetylated in the stable subset arranged in the lamella region, while highly 
dynamic, “pioneer” MTs facing the lamellipodium are de-acetylated [26,27]. GRK2 
directly interacts with and phosphorylates HDAC6 [26], a cytoplasmic histone 
deacetylase responsible for the de-acetylation of tubulin and other substrates involved in 
motility such as cortactin [28]. This phosphorylation event enhances HDAC6-mediated 
α-tubulin (but not cortactin) de-acetylation, and it is required for the positive effect of 
HDAC6 in the migration of epithelial cells and fibroblasts challenged by fibronectin or 
EGF [10,11, 26].  
 The role of MT in cell polarity and motility varies with cell type [27], and might 
be engaged preferentially in the anterior or the posterior cell region. In migrating 
neutrophils and T cells, the MTOC is positioned behind the nucleus and MTs are 
grouped in the uropod, exerting a negative reciprocal feedback loop with RhoA that is 
mandatory for migratory persistence [29].  Both excessive or defective dynamics of 
MTs due to altered levels of GRK2 could compromise uropod specification and 
motility. Conversely, in most other cells the MTOC face the leading edge and more 
dynamic MTs increase protrusive activity. These differences might help to explain the 
prevalence of positive effects of GRK2 in the chemotaxis of epithelial and fibroblastoid 
cells compared to its overall impact in immune cell migration. 
 
GRK2 in cell adhesion and tension: targeting focal adhesions 
 Highly spread epithelial cells and fibroblasts display large adhesions in the 
central lamella during migration, which mature in response to increased actomyosin 
contractility. Simultaneously, nascent and very dynamic focal complexes are formed at 
the lamellipodium by ligand-induced integrin clustering and actin-polymerization in 
order to stabilize membrane protrusion. As traction forces move the cell forward, focal 
adhesions (FA) at the rear must be disassembled. Conversely, round cells seem to 
migrate (either in amoeboid or blebby modes) using weak adhesions around the cell [4]. 
Therefore, cells adopting a mesenchymal mode of migration are more dependent on 
activities that enhance adhesion turnover.  
 GRK2 could stimulate chemotactic migration (and random motility as well) by 
modulating the formation/disassembly of integrin-based cell-extracellular matrix 
contacts (Figure 2). GRK2 expression might favour the nucleation of nascent contacts 
by either facilitating FN- and S1P-directed activation of Rac1 and actin reorganization 
[14] or the transition of integrins to high-affinity conformations important for clustering 
(our unpublished observations). On the other hand, GRK2 weakens FA of epithelial 
cells by increasing the extent and duration of the GIT/PAK/MEK/ERK1/2 signalling 
module upon engagement of integrin receptors, what  promotes FA turnover [14]. 
Interestingly, GRK2 can serve as a RhoA-activated scaffold protein for MAPK 
activation in response to EGF stimulation [30]. In a motile cell, GRK2/RhoA interaction 
would be expected to occur predominantly at the rear edge, wherein RhoA activation 
peaks, and localized MAPK could increase FA turnover.  
Besides, GRK2 might influence the disassembly of FAs by means of the control 
of tubulin deacetylation. Targeting of FAs by dynamic MTs exerts a negative influence 
on focal adhesion maintenance [27]. Upon GRK2 downregulation, hyper-acetylated 
MTs would be less efficient in disassembling FAs, enhancing cell spreading and 
impairing motility [11,24].  
 
Role of GRKs other than GRK2 in cell migration 
 Other GRKs have been reported to modulate cell migration, although 
information about the molecular mechanisms involved is scarce. Comparison of GRKs 
knockout mice in an acute inflammatory arthritis model indicated a role for GRK2, 
GRK3 and GRK6, but not GRK5, in granulocyte migration in such conditions [31, 32]. 
Interestingly, lymphocytes from beta-arrestin-2 and GRK6-deficient animals displayed 
defective chemotaxis towards CXCL12, suggesting a positive role in cell motility in 
such context [33]. 
 GRK5 attenuates atherosclerosis by desensitizing CCR2 in monocytes and 
inhibiting their migration [34]. In epithelial cells, a functional screening identified 
GRK6 as a critical mediator in integrin-mediated cell adhesion and migration of tumor 
cells [35], and GRK6 deficiency reportedly promotes CXCR2 receptor-mediated tumor 
progression and metastasis in a lung carcinoma model [36]. It would be interesting to 
investigate whether the modulation of cell migration by these GRKs is mostly related to 
their canonical role as specific or more active regulators of given GPCRs in different 
cell types or novel substrates and interactors as those identified for GRK2 are also 
targeted.  
 
Physiological and pathological implications 
 Altered activity/expression of GRKs might critically contribute to deregulate cell 
motility in development or wound healing or in pathological situations related to 
inflammation or tumor progression [7, 8, 11,12].  Several GRK2-interacting signalling 
modules play well-known roles in invasive motility, including integrins, GPCRs (such 
as S1P, chemokine or PAR receptors), the EGFR family, RhoA, Rac1, or ERMs [37-
39]. Increased GRK2 levels could strengthen features of tumor cell motility by 
increasing integrin and S1P-mediated signaling, which are amplified in breast cancer 
patients and are critical for invasive migration in 3D-collagen matrices [39-40]. In 
addition, GRK2 could also collaborate with HDAC6 in promoting cytoskeletal and 
adhesion dynamics required for tumoural migration and invasion, as well as in HDAC6-
promoted invadopodial matrix degradation and 3D invasion [11, 26, 41, 42] 
Interestingly, altered GRK2 levels have been found in human granulosa cell tumors, 
thyroid and prostate cancer or some breast tumors (reviewed in [8, 11]), and are up-
regulated in different malignant mammary cell lines displaying aberrant migration [43]. 
Concurrent HDAC6 and GRK2 up-regulation in human tumor malignancies may favor 
migration and invasion, and point these proteins as new potential therapeutic targets for 
suppressing metastasis. 
 On the other hand, GRKs are highly expressed in different cellular types of the 
immune system and are important regulators of inflammation. Decreased GRK2 
activity/levels were found in peripheral blood mononuclear cells of patients and in 
animal models of rheumatoid arthritis and multiple sclerosis [reviewed in 12]. 
Activation of the Toll-like receptor (TLR)-4 pathway promotes GRK2 and GRK5 
transcriptional down-regulation, leading to decreased chemokine receptor 
desensitization and increased migration of polymorphonuclear leukocytes [44]. 
Interestingly, several reports have related the inability of neutrophils from severe sepsis 
patients to migrate towards CXCL2 or CXCL8 chemoattractants, and thus to promote 
bacterial clearance, to increased levels of GRK2 and GRK5 [31]. Notably, sepsis 
attenuation by Interleukin-33 may involve down-modulation of GRK2 expression in 
neutrophils, leading to enhanced CXCR2 signaling and neutrophil chemotaxis [45]. 
Higher up-regulation of GRK2 in diabetic mice exacerbated CXCR2 downregulation 
and reduction of neutrophil migration in sepsis [46]. High GRK2 expression in 
neutrophils from malaria patients suggests a possible mechanism for an enhanced 
susceptibility to secondary bacterial infection during malaria [47].  
 Overall, these data encourage future studies to investigate the role of changes in 
the expression/functionality of GRKs in the triggering or development of physio-
pathological processes related to cell motility. 
 
  Perspectives and conclusions 
 GRKs appear as physiologically relevant integrative nodes in cell migration,.  
Given the distinct signalling and cytoskeleton modules related to chemotaxis potentially 
modulated by GRKs, one key issue is to understand how are orchestrated in response to 
specific stimuli in distinct cell types.  Moreover, an adequate combination of in vitro 
and in vivo experimental approaches is needed to fully decipher the functional role of 
GRKs in motility. 
 GRK2 phosphorylation by other kinases is emerging as a key “signaling switch” 
governing substrate specificity and interaction with cellular partners during cell 
migration (Figure 3). Tyrosine-phosphorylation of GRK2 in response to chemotactic 
signals enhances interaction with GIT1, whereas S670 phosphorylation by MAPK 
displays an opposite effect [14]. In turn, dynamic S670 GRK2 phosphorylation 
specifically allows GRK2 to phosphorylate HDAC6 and thus trigger transient local 
tubulin de-acetylation [26]. Notably, S670 GRK2 phosphorylation by ERK or p38 
Mapk inhibits its interaction with G and prevents GPCR desensitization. [7,8,48]. 
Alternatively, phosphorylation of the FPR1 receptor by p38MAPK has been reported to 
prevent GRK2 recruitment and so facilitate neutrophil migration [17]. Therefore, the 
subcellular localization and phosphorylation status of GRK2 would be a key factor 
underlying the dynamic and stimuli-specific switching of partners relevant to cell 
migration, allowing the sequential and coordinated participation of GRKs in several 
steps of the cell motility process [10,11].  
Lessons and potential bias from experimental models should also be considered. Most 
studies about GRKs in migration are based in in vitro systems (2D-random motility, 
wound healing and transwell assays), and may therefore need further analysis. 
Transwell assays mainly assess cell polarization and persistence, overlooking the 
influence of the structural architecture/biophysical properties of the extracellular matrix. 
2D-substrates favour the mesenchymal migration mode, what may override other 
molecular repertoires that could determine an intrinsically different mode of migration 
(for instance amoeboid-blebby) in physiological/3D environments [49, 50]. 
Furthermore, transwell assays neither reproduce the in vivo complexity of 
superimposing soluble gradients, nor of gradients of matrix-bound factors, which 
intertwinement might alter the mechanisms engaged in the guiding response. We have 
reported that in transwell assays, GRK2 downregulation enhanced migration of 
endothelial cells to both VEGF and FN. However, migration of GRK2-deficient 
endothelial cells in vivo was impaired during the postnatal development of the retinal 
vasculature, as denoted by the reduced advance of endothelial tip cells and impaired 
filopodia formation and/or stabilization [51].  For proper migration in vivo, VEGF is 
anchored to fibrillar fibronectin depots assembled on the cellular projections of retinal 
astrocytes, which provide a guiding scaffold [52,53], in contrast to the presentation of 
these chemotactic cues in vitro. GRK2 might play in vivo additional roles in the 
integration of fibronectin and VEGF signals, positively influencing guiding persistence 
and migration, as previously described for the intertwinement of integrins and S1P 
receptors in epithelial cells [14]. Combined experiments in classical, 3D and in vivo 
experimental models will help to better assess the role of GRKs in cell migration and to 
define the underlying molecular mechanisms. 
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Figure legends 
Figure1.- Proposed model for the role of GRK2 in the modulation of chemotactic 
gradient sensing. Local fraction of receptor occupancy by chemoattractants would 
trigger stimulatory signals for the generation of internal signalling asymmetry, whereas 
global levels of occupied receptors would inhibit this parameter [16]. In the presence of 
lower GRK2 levels/activity, stimulated GPCR would remain longer/more functional in 
the membrane, thus eliciting robust directional sensing responses and the specification 
of stable pseudopodia as if the gradient was steeper. Conversely, excessive GRK2 
activity would diminish the global level of occupied receptors, resulting in the inability 
to differentiate the cell front from the back, as occurs in the absence of gradients, 
resulting in cessation of movement. 
Figure 2.- Different GRK2 substrates and interactors in the modulation of cell 
polarization membrane protrusion and adhesion. By dynamically interacting with 
diverse substrates and effectors in different cellular locations, GRK2 may modulate 
several facets of the cell migration machinery in a stimuli- and cellular context-
dependent manner. FA, focal adhesions; FC, focal contacts. 
Figure 3.- GRK2 phosphorylation by other kinases as a “signalling switch” 
governing substrate specificity and interaction with cellular partners during cell 
migration. Migratory stimuli would trigger GRK2 recruitment to activated GPCR in 
the lamellipodium membrane. At such specific locations, chemokine receptor 
stimulation would promote the transient Src-mediated tyrosine phosphorylation of 
GRK2, enhancing its interaction with GIT1 and facilitating localized activation of the 
Rac/Pak/Mek/Erk pathway. Subsequent phosphorylation of GRK2 at S670 by MAPK 
disrupts interactions with GIT-1 and GPCR, simultaneously switching on the ability of 
GRK2 to phosphorylate HDAC6 co-localized at the lamellipodium. Both phospho-
S670-GRK2 and HDAC6 are specifically co-recruited to pseudopodia in response to 
pro-migratory stimuli, resulting into dynamic, local HDAC6-mediated de-acetylation of 
MTs. The concerted action of hipo-acetylated MTs and GIT1 signalosomes at the 
leading edge would contribute to cortical polarity and membrane protrusion and thus 
lead to enhanced cell motility. 
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Table1. The overall effect of altering GRK2 levels/activity on chemotactic 
migration depends on stimuli, cell type and migration assays 
 
*our unpublished data 
Cellular type 
GRK2 
expression/functionality 
Migration outcome to 
chemoattractants 
Experimental 
migration assay 
Epithelial cells 
and fibroblasts 
Decreased 
 
Over-expressed 
 
Reduced to FN14,26, 
serum26,24, S1P14 
 
Increased to FN14,26, 
serum26, S1P14 
Transwell14,26 
Wound-healing 
in vivo14 and in 
vitro26,24 
 
Endothelial cells 
 
Decreased 
Increased to VEGF51, FN51 
 
Reduced to VEGF51 
Transwell51 
 
In vivo retina51 
Vascular smooth 
muscle cells 
Over-expressed 
Decreased to PDGF 54,  
and AngII 55 
 
Unchanged to EGF54 
Transwell54,55 
 
Basophilic cells 
 
Decreased Reduced to fMLP* 
 
   Transwell* 
 
Lymphocytes 
 
 
Decreased 
 
 
 
Increased to S1P13, 
 CCL356, CCL456 
 
Reduced to CCL2113 
 
 
Transwell13, 56 
 
In vivo lymph 
node entry13 
 
Neutrophils 
Increased 
 
 
Decreased 
 
Decreased to fMLP17, 
LTB431, IL831 
 
Increased to CXCL2 44  
Transwell31, 44 
2-D tracking17 
Monocytes Decreased 
Unchanged to CCL248 
Reduced to MCP-1 plus 
LPS48 
 
Increased to CCL557 
Transwell48 
 
intraperitoneal 
mobilization57 
 
Granulocytes 
 
Decreased 
Increased to LTB458 
Unchanged to IL858, C5a58 
Transendothelial 
migration58 
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